Xu Lin, He Hua, Du Yutong, Zhang Shengwei, Yu Deng-Guang, Liu Ping
School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai 200093, China.
The Third Affiliated Hospital, Naval Medical University, Shanghai 200433, China.
Pharmaceutics. 2023 Sep 13;15(9):2314. doi: 10.3390/pharmaceutics15092314.
Smart drug delivery, through which the drug molecules are delivered according to the requests of human biological rhythms or by maximizing drug therapeutic effects, is highly desired in pharmaceutics. Many biomacromolecules have been exploited for this application in the past few decades, both in industry and laboratories. Biphasic release, with an intentional pulsatile release and a following extended release stage, represents a typical smart drug delivery approach, which aims to provide fast therapeutic action and a long time period of effective blood drug concentration to the patients. In this study, based on the use of a well-known biomacromolecule, i.e., cellulose acetate (CA), as the drug (acetaminophen, ATP)-based sustained release carrier, a modified coaxial electrospraying process was developed to fabricate a new kind of core-shell nanoparticle. The nanoparticles were able to furnish a pulsatile release of ATP due to the shell polyvinylpyrrolidone (PVP). The time cost for a release of 30% was 0.32 h, whereas the core-shell particles were able to provide a 30.84-h sustained release of the 90% loaded ATP. The scanning electron microscope and transmission electron microscope results verified in terms of their round surface morphologies and the obvious core-shell double-chamber structures. ATP presented in both the core and shell sections in an amorphous state owing to its fine compatibility with CA and PVP. The controlled release mechanisms of ATP were suggested. The disclosed biomacromolecule-based process-structure-performance relationship can shed light on how to develop new sorts of advanced nano drug delivery systems.
智能药物递送是药剂学中非常期望实现的,通过这种方式,药物分子可根据人体生物节律的要求或通过最大化药物治疗效果来进行递送。在过去几十年里,无论是在工业领域还是实验室中,许多生物大分子都已被用于此应用。双相释放,即有意的脉冲式释放以及随后的缓释阶段,代表了一种典型的智能药物递送方法,其目的是为患者提供快速的治疗作用以及长时间的有效血药浓度。在本研究中,基于使用一种知名的生物大分子,即醋酸纤维素(CA),作为基于药物(对乙酰氨基酚,ATP)的缓释载体,开发了一种改进的同轴电喷雾工艺来制备一种新型的核壳纳米颗粒。由于壳层的聚乙烯吡咯烷酮(PVP),这些纳米颗粒能够实现ATP的脉冲式释放。释放30%所需的时间为0.32小时,而核壳颗粒能够对负载的90%的ATP提供30.84小时的持续释放。扫描电子显微镜和透射电子显微镜的结果在其圆形表面形态和明显的核壳双腔结构方面得到了验证。由于ATP与CA和PVP具有良好的相容性,它在核部和壳部均以无定形状态存在。提出了ATP的控释机制。所揭示的基于生物大分子的过程 - 结构 - 性能关系可为如何开发新型先进的纳米药物递送系统提供启示。